Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
7-10 Yr Trsy Bear 3X Direxion | TYO | 11. oct 2024 | 13.38 | +0.09 |
7-10 Yr Trsy Bull 3X Direxion | TYD | 11. oct 2024 | 26.36 | 0.00 |
7-10 Yr Trsy Ishares | IEF | 11. oct 2024 | 95.86 | +0.03 |
89bio | ETNB | 11. oct 2024 | 7.79 | +4.70 |
8x8 | EGHT | 11. oct 2024 | 1.96 | +5.38 |
908 Devices | MASS | 11. oct 2024 | 3.47 | +4.52 |
99 Acquisition Group | NNAGU | 11. oct 2024 | 10.60 | 0.00 |
99 Acquisition Group | NNAG | 11. oct 2024 | 10.55 | 0.00 |
9F ADR | JFU | 11. oct 2024 | 1.80 | -1.64 |
A SPAC II Acquisition | ASCB | 11. oct 2024 | 11.19 | 0.00 |
A-Mark Precious Metals | AMRK | 11. oct 2024 | 41.93 | +1.43 |
a.k.a Brands | AKA | 11. oct 2024 | 23.04 | +3.41 |
A.O Smith | AOS | 11. oct 2024 | 80.87 | -6.25 |
A10 Networks | ATEN | 11. oct 2024 | 14.91 | +0.88 |
A2Z Cust2Mate Solutions | AZ | 11. oct 2024 | 2.84 | +6.77 |
AA Mission Acquisition | AAM | 11. oct 2024 | 10.02 | 0.00 |
AAA - A Rated Corporate Bond Ishares | QLTA | 11. oct 2024 | 48.31 | -0.07 |
Aadi Bioscience | AADI | 11. oct 2024 | 2.05 | +3.02 |
AAON | AAON | 11. oct 2024 | 112.45 | +3.55 |
AAR | AIR | 11. oct 2024 | 61.51 | +3.47 |
Abacus Life | ABL | 11. oct 2024 | 10.24 | +5.13 |
Abbott Laboratories | ABT | 11. oct 2024 | 116.12 | +0.43 |
AbbVie | ABBV | 11. oct 2024 | 194.19 | -0.08 |
AbCellera Biologics | ABCL | 11. oct 2024 | 2.59 | +3.60 |
Abeona Therapeutics | ABEO | 11. oct 2024 | 6.41 | -2.58 |
Abercrombie & Fitch | ANF | 11. oct 2024 | 149.75 | +4.54 |
Aberdeen Asia-Pacificome Fund | FAX | 11. oct 2024 | 16.96 | -0.35 |
Aberdeen Australia Equity Fund | IAF | 11. oct 2024 | 4.58 | +0.22 |
Aberdeen Emerging Markets Fund | AEF | 11. oct 2024 | 5.68 | +0.35 |
Aberdeen Global Fund | FCO | 11. oct 2024 | 6.02 | +0.17 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.